Current treatment guidelines and glycated haemoglobin goals for type 2 diabetes: Which patients are most likely to benefit from fixed-ratio basal insulin glucagon-like peptide-1 receptor agonist combinations?
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Current treatment guidelines and glycated haemoglobin goals for type 2 diabetes: Which patients are most likely to benefit from fixed-ratio basal insulin glucagon-like peptide-1 receptor agonist combinations?
- Published In:
- Diabetes, obesity & metabolism, 27 Suppl 7(Suppl 7), 3-13 (2025)
- Authors:
- Cowart, Kevin(2), Carris, Nicholas W
- Database ID:
- RPEP-10557
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-10557APA
Cowart, Kevin; Carris, Nicholas W. (2025). Current treatment guidelines and glycated haemoglobin goals for type 2 diabetes: Which patients are most likely to benefit from fixed-ratio basal insulin glucagon-like peptide-1 receptor agonist combinations?. Diabetes, obesity & metabolism, 27 Suppl 7(Suppl 7), 3-13. https://doi.org/10.1111/dom.16502
MLA
Cowart, Kevin, et al. "Current treatment guidelines and glycated haemoglobin goals for type 2 diabetes: Which patients are most likely to benefit from fixed-ratio basal insulin glucagon-like peptide-1 receptor agonist combinations?." Diabetes, 2025. https://doi.org/10.1111/dom.16502
RethinkPeptides
RethinkPeptides Research Database. "Current treatment guidelines and glycated haemoglobin goals ..." RPEP-10557. Retrieved from https://rethinkpeptides.com/research/cowart-2025-current-treatment-guidelines-and
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.